Build your portfolio of top-class funds today.
Start systematic investing now!
Tata India Pharma & Healthcare Fund - Growth - Direct Plan has delivered CAGR and average rolling returns as follows :
1 Year | 3 Year | 5 Year | 9 Year | |
CAGR(%) | 57 | 21.5 | 27.51 | N/A |
Average Rolling Returns(%) | 17.21 | 15.20 | 16.28 | N/A |
The Current NAV of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is ₹33.92.
You can consider SIP in Tata India Pharma & Healthcare Fund - Growth - Direct Plan as it has consistently outperformed the benchmark and has a Very good quality portfolio. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
Tata India Pharma & Healthcare Fund - Growth - Direct Plan fund’s expense ratio is 0.69%
The process for redemption is
The AUM of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is currently ₹1,208 Crores.
The Top three stocks are Sun Pharma Inds., Aurobindo Pharma and Lupin and account for 28% of its portfolio. Top 5 and 10 stocks of fund account for 41% and 62% of fund’s portfolio respectively.
Top three sectors of Tata India Pharma & Healthcare Fund - Growth - Direct Plan fund are Healthcare, Miscellaneous and Chemicals accounting for 99% of the total portfolio.
Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of Tata India Pharma & Healthcare Fund - Growth - Direct Plan Fund is Equity - Sectoral Fund - Pharma & Health Care.
Meeta Shetty and Rajat Srivastava manage the Tata India Pharma & Healthcare Fund - Growth - Direct Plan Fund.
Tata India Pharma & Healthcare Fund - Growth - Direct Plan current PE ratio is 45.00 and PB ratio is 6.60
The asset allocation of Tata India Pharma & Healthcare Fund - Growth - Direct Plan is Stocks : 94.61%, Debt : 5.38% and Gold : 0%
The minimum SIP amount for Tata India Pharma & Healthcare Fund - Growth - Direct Plan is ₹100.00 and minimum lumpsum is ₹5000.00
The exit load for Tata India Pharma & Healthcare Fund - Growth - Direct Plan is 0.25% on or before 30 days